A couple of things of interest in an article about PEB in todays NBR.
David Darling mentioned that the initial share offer to institutional and habitual investors in the latest capital raising had been significantly oversubscribed and that the demand will flow on through to the tradeable rights which will come from the rights issue.
The company expects to have US licenses and to be market ready in March 2013. The first US customer has a private practice in New Jersey that has 120 urologists in it, about three times as many as there are in NZ.
I hope to make the trip south to attend the AGM on the 25th. Should be interesting.